Expand FBIO Menu
FBIO MENU

FBIO Latest Press Releases

-- December 15, 2025 --

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission Globe Newswire 8:00 AM

-- December 10, 2025 --

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology Globe Newswire 8:30 AM

-- November 14, 2025 --

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 8:30 AM

-- November 12, 2025 --

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 4:01 PM

-- November 6, 2025 --

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics Globe Newswire 7:00 AM

-- November 5, 2025 --

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 Globe Newswire 8:30 AM

-- October 28, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PRNewswire 10:00 AM

-- October 24, 2025 --

Journey Medical Corporation Reports Combined Emrosi (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference Globe Newswire 8:30 AM

-- October 23, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PRNewswire 10:08 AM

-- October 21, 2025 --

Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics' Global Phase 3 Trials of Dotinurad for the Treatment of Gout Globe Newswire 8:30 AM

-- October 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PRNewswire 10:01 AM

-- October 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PRNewswire 1:50 PM

-- October 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PRNewswire 5:45 PM
Journey Medical Corporation to Participate in October 2025 Investor Conferences Globe Newswire 8:30 AM

-- October 1, 2025 --

Fortress Biotech Investigated by the Portnoy Law Firm Globe Newswire 3:45 PM
INVESTOR ALERT: Investigation of Fortress Biotech, Inc. (FBIO) Announced by Holzer & Holzer, LLC Globe Newswire 11:58 AM
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics' $205 Million Series A Financing Globe Newswire 8:05 AM
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101 Globe Newswire 8:00 AM

-- September 3, 2025 --

Journey Medical Corporation to Participate in September 2025 Investor Conferences Globe Newswire 8:30 AM

-- September 2, 2025 --

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 8:30 AM

-- August 18, 2025 --

Journey Medical Corporation to Present at the Emerging Growth Conference Globe Newswire 8:30 AM

-- August 14, 2025 --

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- August 12, 2025 --

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 4:01 PM

-- August 7, 2025 --

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 Globe Newswire 8:30 AM

-- August 5, 2025 --

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 Globe Newswire 4:01 PM
Market Data Delayed 15 Minutes